Summary
In a study of 32 patients, there were 29 cases of intra-uterine foetal death and 3 cases of hydatidiform mole. The intravenous administration of either prostaglandin E1, E2 or F2x successfully induced labour in 29 out of the 32 cases. Two patients delivered following additional intravenous oxytocin and there was one failure due to the development of upper limb cyanosis. Side-effects included vomiting, phlebitis, facial flushing, rigors, pyrexia and uterine hypertonus. The method confirms the high success rates reported previously but the incidence of side-effects was disturbing. It is emphasised that prostaglandin E1 was used during this original research trial when prostaglandins were first investigated clinically. Prostaglandin E^ has not been made available commercially.